ML
Michael Lillestol
Physician · Internal Medicine Associates
Credentials: · · ·
History
Research
A 52-week placebo-controlled trial of evolocumab in hyperlipidemia
New England Journal of Medicine · 2014 · 596 citations
Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate
Osteoporosis International · 2011 · 82 citations
Journal of Clinical Hypertension · 2011 · 13 citations
- AM
2 papers
- DH
2 papers
- DD
2 papers
- EC
2 papers
- MW
2 papers
- PK
2 papers
- SN
2 papers

1 paper

